Our investments

Biokinesis

Biokinesis, founded in October 2011, is a biotechnology company developing new treatments for cancer by targeting a specific kinesin found in several cancers. Biokinesis has so far had very good results on several types of animals.

Dr Philippe Pouletty and Antoine Pau are Board members.

First FinTech Closing
On the 15th of November 2017, Truffle has successfully completed the first closing of its institutional fund Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.